Drug Shortage Report for SANDOZ AZITHROMYCIN

Last updated on 2022-06-23 History
Report ID 163234
Drug Identification Number 02332396
Brand name SANDOZ AZITHROMYCIN
Common or Proper name AZITHROMYCIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 200MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 37,5ML POS
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-06-22
Estimated end date 2022-07-08
Actual end date
Shortage status Actual shortage
Updated date 2022-06-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-06-23 English Compare
v2 2022-06-22 French Compare
v1 2022-06-22 English Compare

Showing 1 to 3 of 3